We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $801M
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+23.14%
3 Year Est. Return
+51.97%
5 Year Est. Return
+52.71%
10 Year Est. Return
+183.03%
AUM
$801M
AUM Growth
-$135M
Cap. Flow
-$185M
Cap. Flow %
-23.05%
Top 10 Hldgs %
61.88%
Holding
39
New
6
Increased
7
Reduced
15
Closed
5
Avg Time Held
6.9 quarters
Top 10 Avg Time Held
3.6 quarters
Top 20 Avg Time Held
6.9 quarters

Sector Composition

Rank Sector Weight
1 Healthcare 46.18%
2 Industrials 11.4%
3 Technology 9.17%
4 Real Estate 8.09%
5 Consumer Discretionary 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ATAI icon
26
DELISTED
AtaiBeckley Inc
ATAI
$6.26M 0.78%
1,187,808
-593,895
-33% -$2.5M
2026 Q1
1 quarter
SRG icon
27
Seritage Growth Properties
SRG
$88.4M
$5.96M 0.74%
2,266,230
+2,225,110
+5,411% +$5.85M
2026 Q1
1 quarter
ELME icon
28
Elme Communities
ELME
$156M
$3.7M 0.46%
2,500,000
+2,189,739
+706% +$4.44M
2026 Q1
1 quarter
FSP icon
29
Franklin Street Properties
FSP
$37.5M
$3.68M 0.46%
7,150,000
– –
2024 Q2
8 quarters
VCX icon
30
Fundrise Innovation Fund
VCX
$914M
$3.46M 0.43%
+40,000
New +$5.72M
2026 Q2
0 quarters
ZOOZ icon
31
ZOOZ Strategy Ltd
ZOOZ
$54.5M
$2.98M 0.37%
537,499
-132,729
-20% -$782K
2025 Q4
2 quarters
WVE icon
32
Wave Life Sciences
WVE
$646M
$1.25M 0.16%
215,000
-85,000
-28% -$564K
2022 Q2
16 quarters
MREO icon
33
Mereo BioPharma
MREO
$50.3M
$953K 0.12%
3,000,000
-4,079,056
-58% -$1.22M
2025 Q4
2 quarters
ENHA icon
34
Enhanced Group Inc
ENHA
$205M
$287K 0.04%
+99,998
New +$667K
2026 Q2
0 quarters
VISN icon
35
Vistance Networks Inc
VISN
$1.4B
– –
-3,762,713
Closed -$68.5M –
QURE icon
36
uniQure
QURE
$1.51B
– –
-87,684
Closed -$1.43M –
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$1.51B
– –
-400,000
Closed -$8.38M –
DXYZ icon
38
Destiny Tech100
DXYZ
$923M
– –
-345,000
Closed -$9.24M –
USAR icon
39
USA Rare Earth Inc
USAR
$4.44B
– –
-2,339,613
Closed -$35.4M –

Similar funds

Newtyn Management's Q2 2026 Portfolio in Review

As of Q2 2026, Newtyn Management held 39 positions worth $801M, down 14% from $936M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Newtyn Management withdrew a net $185M in Q2 2026, closing 5 positions and reducing 15 holdings. Its most notable exit was Vistance Networks Inc, an estimated $68.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 36% a quarter earlier, followed by Industrials and Technology.

Against the trend, Newtyn Management opened a new position in Octave Intelligence worth $31.3M.

  • Newtyn Management's largest Q2 2026 buy was Octave Intelligence: 1,922,160 shares worth $31.3M.
  • Newtyn Management added most to QuidelOrtho in Q2 2026, an estimated $27.3M increase.
  • Newtyn Management's biggest Q2 2026 reduction was Enviri, cutting an estimated $102M.
  • Newtyn Management fully exited Vistance Networks Inc in Q2 2026, selling an estimated $68.5M.
  • Newtyn Management's ten largest holdings make up 62% of its $801M portfolio in Q2 2026.
  • Newtyn Management opened 6 new positions and closed 5 in Q2 2026.
  • Newtyn Management's portfolio value fell 14% quarter-over-quarter to $801M.

Based on Newtyn Management's 13F filing for Q2 2026, filed 14 Aug 2026.